Page last updated: 2024-08-21

chenodeoxycholic acid and suvanine

chenodeoxycholic acid has been researched along with suvanine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
D'Amore, C; D'Auria, MV; De Marino, S; Di Leva, FS; Festa, C; Fiorucci, S; Limongelli, V; Novellino, E; Renga, B; Zampella, A	1

Other Studies

1 other study(ies) available for chenodeoxycholic acid and suvanine

Article	Year
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. Journal of medicinal chemistry, 2013, Jun-13, Volume: 56, Issue:11 Topics: Animals; Binding Sites; Chenodeoxycholic Acid; Co-Repressor Proteins; Genes, Reporter; Hep G2 Cells; Humans; Ligands; Luciferases; Membrane Transport Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Nuclear Receptor Coactivator 1; Porifera; Promoter Regions, Genetic; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Sesterterpenes; Structure-Activity Relationship; Transcriptional Activation	2013

Article

Year

Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands.

Journal of medicinal chemistry, 2013, Jun-13, Volume: 56, Issue:11

Topics: Animals; Binding Sites; Chenodeoxycholic Acid; Co-Repressor Proteins; Genes, Reporter; Hep G2 Cells; Humans; Ligands; Luciferases; Membrane Transport Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Nuclear Receptor Coactivator 1; Porifera; Promoter Regions, Genetic; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Sesterterpenes; Structure-Activity Relationship; Transcriptional Activation

2013